191 related articles for article (PubMed ID: 26471868)
1. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
3. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
[TBL] [Abstract][Full Text] [Related]
4. The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma.
Chikaishi Y; Uramoto H; Tanaka F
Anticancer Res; 2011 Dec; 31(12):4451-6. PubMed ID: 22199314
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.
Matsubara T; Tagawa T; Takada K; Toyokawa G; Shimokawa M; Kozuma Y; Akamine T; Haro A; Osoegawa A; Mori M
Clin Lung Cancer; 2019 Jul; 20(4):e504-e513. PubMed ID: 31103348
[TBL] [Abstract][Full Text] [Related]
7. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.
Shi Y; Wu H; Zhang M; Ding L; Meng F; Fan X
Diagn Pathol; 2013 May; 8():89. PubMed ID: 23706092
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Kim S; Koh J; Kim MY; Kwon D; Go H; Kim YA; Jeon YK; Chung DH
Hum Pathol; 2016 Dec; 58():7-14. PubMed ID: 27473266
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.
Pore M; Meijer C; de Bock GH; Boersma-van Ek W; Terstappen LW; Groen HJ; Timens W; Kruyt FA; Hiltermann TJ
Clin Lung Cancer; 2016 Nov; 17(6):535-542. PubMed ID: 27363902
[TBL] [Abstract][Full Text] [Related]
10. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
11. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
[TBL] [Abstract][Full Text] [Related]
12. Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
Koh YW; Han JH; Haam S
Pathology; 2021 Feb; 53(2):239-246. PubMed ID: 33036771
[TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial-mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma.
Neri S; Menju T; Sowa T; Yutaka Y; Nakajima D; Hamaji M; Ohsumi A; Chen-Yoshikawa TF; Sato T; Sonobe M; Yoshizawa A; Haga H; Date H
Lung Cancer; 2019 Feb; 128():13-19. PubMed ID: 30642445
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
Koh YW; Han JH; Jeong D; Kim CJ
Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
[TBL] [Abstract][Full Text] [Related]
18. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C
Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.
Zhao M; Zhang Y; Zhang H; Wang S; Zhang M; Chen X; Wang H; Zeng G; Chen X; Liu G; Zhou C
Lung Cancer; 2015 Feb; 87(2):98-106. PubMed ID: 25512094
[TBL] [Abstract][Full Text] [Related]
20. FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.
Qi L; Song W; Li L; Cao L; Yu Y; Song C; Wang Y; Zhang F; Li Y; Zhang B; Cao W
Oncotarget; 2016 Nov; 7(45):74015-74030. PubMed ID: 27677589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
